石药集团(01093.HK) 公布，附属石药创新(300765.SZ) 发盈警，预计2024年度归属股东净利润介乎4,500万至6,600万人民币，较上年度倒退84.8%-89.6%。原因是公司功能性原料业务因咖啡因价格回落，收入有所下降；及多款在研产品取得重要进展，研发费用投入加大。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2025-01-17 16:25。) (A股报价延迟最少十五分钟。)
| 公布日期 | 派息事项 | 派息内容 |
|---|---|---|
| 2024/11/15 | 第三季业绩 | 无派息 |
| 2024/08/21 | 中期业绩 | 股息：港元 0.1600 |
| 2024/05/27 | 第一季业绩 | 无派息 |
| 2024/03/20 | 末期业绩 | 股息：港元 0.1400 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.